Breaking News Instant updates and real-time market news.

PDCO

Patterson Companies

$47.51

1.02 (2.19%)

09:39
11/22/16
11/22
09:39
11/22/16
09:39

Patterson Companies tests 52-week low after earnings miss expectations

The stock was last at $38.50, down over 18.5%. At that price next support is at $37.66. Resistance is at $39.60.

  • 22

    Nov

PDCO Patterson Companies
$47.51

1.02 (2.19%)

10/05/16
UBSW
10/05/16
INITIATION
Target $48
UBSW
Neutral
Patterson Companies initiated with a Neutral at UBS
Target $48.
11/01/16
NRCS
11/01/16
NO CHANGE
NRCS
Amazon.com should partner with Patterson Companies, says Northcoast
Northcoast said Amazon.com (AMZN) has a strong interest in entering the dental market and has spent time and resources attempting to build relationships with manufacturers and distributors to gain product procurement, which so far has been unsuccessful. The firm's analyst said Patterson (PDCO) is aggressively trying to reinvent how dental distribution will occur in the future and is building a new IT backbone, making huge investments in technical service. Northcoast said Patterson is on a path to disrupt the industry and could accelerate this effort with a partnership with Amazon. The firm continues to view Patterson as undervalued, with out without Amazon, and recommends investors build positions at this time.
11/21/16
BARD
11/21/16
NO CHANGE
BARD
Outperform
Baird expects Amazon.com distribution announcement with Patterson
Following industry conversions, Baird analyst Jeff Johnson expects Patterson Companies (PDCO) to announce an Amazon.com (AMZN) distribution agreement tomorrow. What the analyst hadnt considered and is now hearing is that Amazon could fulfill orders placed through Patterson's order portal, lowering Patterson's fulfillment costs and given the company breathing room as it pursues DSO deals. Johnson rates Patterson a Neutral with a $48 price target.
11/22/16
PIPR
11/22/16
NO CHANGE
PIPR
Patterson cancellation a positive for Dentsply, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien believes Patterson Companies (PDCO) cancelling its exclusive selling agreement with legacy Sirona products beyond September 2017 as positive for Dentsply Sirona (XRAY). The move is unsurprising given the changing industry dynamics, O'Brien tells investors in a research note. He points out that the initial exclusive agreement was established in 1998. Assuming Henry Schein (HSIC) starts selling legacy Sirona equipment, the cancellation is a positive for Dentsply as this will ultimately allow the company to increase cross-selling opportunities with those customers, O'Brien argues. He's been calling for a cancellation of the exclusive selling agreement with Patterson saying Dentsply has been adamant about realizing sales synergies through increased cross-selling opportunities. The analyst reiterates an Overweight rating on Dentsply with a $70 price target. Patterson in pre-market trading is down 17% to $39.20 after reporting a decline in North American dental consumables sales of 2.5%. Dentsply shares are down 2% to $58.40.

TODAY'S FREE FLY STORIES

KO

Coca-Cola

$43.40

0.33 (0.77%)

13:05
04/24/17
04/24
13:05
04/24/17
13:05
Technical Analysis
Coca-Cola technical comments ahead of results »

There is a bullish…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 09

    May

REED

Reed's

13:05
04/24/17
04/24
13:05
04/24/17
13:05
Earnings
Reed's sees Q1 revenue $8.3M vs. $10M last year »

Reed's said it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

13:05
04/24/17
04/24
13:05
04/24/17
13:05
General news
FX Action: USD-CAD »

FX Action: USD-CAD topped…

REED

Reed's

13:03
04/24/17
04/24
13:03
04/24/17
13:03
Hot Stocks
Reed's founder and CEO resigns, becomes Chief Innovation Officer »

Reed's announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

REED

Reed's

13:02
04/24/17
04/24
13:02
04/24/17
13:02
Syndicate
Reed's closes $3.4M private placement »

Reed's announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

BDX

Becton Dickinson

$178.36

-6.93 (-3.74%)

13:00
04/24/17
04/24
13:00
04/24/17
13:00
Upgrade
Becton Dickinson rating change  »

Becton Dickinson upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 04

    May

  • 06

    Jun

JNJ

Johnson & Johnson

$122.72

0.96 (0.79%)

, NVS

Novartis

$74.36

0.955 (1.30%)

12:57
04/24/17
04/24
12:57
04/24/17
12:57
Periodicals
J&J, Novartis, Takeda in talks over Hypermarcas takeover, Reuters says »

Johnson & Johnson…

JNJ

Johnson & Johnson

$122.72

0.96 (0.79%)

NVS

Novartis

$74.36

0.955 (1.30%)

TKPYY

Takeda Pharmaceutical Co. Ltd.

$24.29

0.215 (0.89%)

HYPMY

Hypermarcas

$9.66

0.44 (4.77%)

BBD

Banco Bradesco

$10.17

0.33 (3.35%)

CS

Credit Suisse

$15.16

0.705 (4.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 06

    Jun

  • 26

    Jun

REED

Reed's

12:56
04/24/17
04/24
12:56
04/24/17
12:56
Hot Stocks
Breaking Hot Stocks news story on Reed's »

Reed's trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

AMZN

Amazon.com

$898.53

-3.53 (-0.39%)

, W

Wayfair

$46.66

0.7 (1.52%)

12:55
04/24/17
04/24
12:55
04/24/17
12:55
Periodicals
Amazon hopes to launch furniture seller program, Furniture Today reports »

In a report highlighted…

AMZN

Amazon.com

$898.53

-3.53 (-0.39%)

W

Wayfair

$46.66

0.7 (1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 27

    Apr

  • 09

    May

  • 16

    May

  • 17

    May

  • 23

    May

MMM

3M

$193.60

2.1 (1.10%)

12:55
04/24/17
04/24
12:55
04/24/17
12:55
Technical Analysis
3M technical notes before earnings news »

The stock has recently…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

  • 31

    May

CAT

Caterpillar

$96.85

2.53 (2.68%)

12:52
04/24/17
04/24
12:52
04/24/17
12:52
Earnings
On The Fly: What to watch in Caterpillar earnings report »

Caterpillar (CAT) is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 09

    May

  • 14

    Jun

MU

Micron

$27.32

-0.64 (-2.29%)

12:51
04/24/17
04/24
12:51
04/24/17
12:51
Options
Bullish sentiment in Micron May 5th options ahead of a company event »

Bullish sentiment in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 07

    Jun

AKRX

Akorn

$32.91

-0.09 (-0.27%)

, FSNUY

Fresenius SE

$19.67

-0.16 (-0.81%)

12:50
04/24/17
04/24
12:50
04/24/17
12:50
Periodicals
Akorn close to buyout deal at $33-$35/share, Reuters reports »

Akorn (AKRX) is near a…

AKRX

Akorn

$32.91

-0.09 (-0.27%)

FSNUY

Fresenius SE

$19.67

-0.16 (-0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSU

Kansas City Southern

$89.22

1.23 (1.40%)

12:49
04/24/17
04/24
12:49
04/24/17
12:49
Hot Stocks
Fitch: Mexican regulation could pressure Kansas City Southern »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 09

    May

AKRX

Akorn

$32.91

-0.09 (-0.27%)

, FSNUY

Fresenius SE

$19.67

-0.16 (-0.81%)

12:47
04/24/17
04/24
12:47
04/24/17
12:47
Periodicals
Breaking Periodicals news story on Akorn, Fresenius SE »

Sources: Fresenius could…

AKRX

Akorn

$32.91

-0.09 (-0.27%)

FSNUY

Fresenius SE

$19.67

-0.16 (-0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKRX

Akorn

$32.91

-0.09 (-0.27%)

, FSNUY

Fresenius SE

$19.67

-0.16 (-0.81%)

12:44
04/24/17
04/24
12:44
04/24/17
12:44
Periodicals
Breaking Periodicals news story on Akorn, Fresenius SE »

Fresenius nears deal to…

AKRX

Akorn

$32.91

-0.09 (-0.27%)

FSNUY

Fresenius SE

$19.67

-0.16 (-0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMA

Comerica

$70.71

2 (2.91%)

12:41
04/24/17
04/24
12:41
04/24/17
12:41
Options
Notable call write in Comerica as shares rally »

Notable call write in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

CRHM

CRH Medical

$5.75

-1.6 (-21.77%)

12:40
04/24/17
04/24
12:40
04/24/17
12:40
Recommendations
CRH Medical analyst commentary  »

Cantor discusses recent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

GOOG

Alphabet

$843.19

1.54 (0.18%)

, GOOGL

Alphabet Class A

$858.95

-1.13 (-0.13%)

12:36
04/24/17
04/24
12:36
04/24/17
12:36
Hot Stocks
Google adds TV to 'DoubleClick' ad buying platform »

Google announced in its…

GOOG

Alphabet

$843.19

1.54 (0.18%)

GOOGL

Alphabet Class A

$858.95

-1.13 (-0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 22

    May

ORAN

Orange SA

$15.98

0.935 (6.22%)

, FB

Facebook

$143.68

-0.12 (-0.08%)

12:36
04/24/17
04/24
12:36
04/24/17
12:36
Hot Stocks
Orange partners with Facebook to launch startup accelerator »

Orange is working with…

ORAN

Orange SA

$15.98

0.935 (6.22%)

FB

Facebook

$143.68

-0.12 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

BIIB

Biogen

$272.94

0.48 (0.18%)

12:32
04/24/17
04/24
12:32
04/24/17
12:32
Technical Analysis
Biogen technical remarks ahead of earnings news »

The stock has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 31

    May

XOP

SPDR Oil Exploration and Production Fund

$35.41

0.3 (0.85%)

12:31
04/24/17
04/24
12:31
04/24/17
12:31
Options
Defensive option play in SPDR Oil Exploration and Production ETF »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALXN

Alexion

$116.82

-1.9 (-1.60%)

12:26
04/24/17
04/24
12:26
04/24/17
12:26
Options
Alexion call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 23

    Oct

MCK

McKesson

$136.22

0.3 (0.22%)

, TSRO

Tesaro

$136.01

-3 (-2.16%)

12:26
04/24/17
04/24
12:26
04/24/17
12:26
Hot Stocks
Biologics Inc says selected as specialty pharmacy provider for Tesaro's Zejula »

Biologics Inc, a McKesson…

MCK

McKesson

$136.22

0.3 (0.22%)

TSRO

Tesaro

$136.01

-3 (-2.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

  • 30

    Jun

AGN

Allergan

$238.06

1.71 (0.72%)

, BIIB

Biogen

$272.94

0.48 (0.18%)

12:25
04/24/17
04/24
12:25
04/24/17
12:25
Conference/Events
Piper Jaffray biopharma analysts hold an analyst/industry conference call »

Biopharmaceuticals…

AGN

Allergan

$238.06

1.71 (0.72%)

BIIB

Biogen

$272.94

0.48 (0.18%)

CARA

Cara Therapeutics

$16.53

-0.56 (-3.28%)

COLL

Collegium Pharmaceutical

$10.24

0.19 (1.89%)

EGLT

Egalet

$4.24

0.02 (0.47%)

ENDP

Endo

$10.29

-0.19 (-1.81%)

NKTR

Nektar

$18.37

-0.76 (-3.97%)

PFE

Pfizer

$33.82

0.18 (0.54%)

TEVA

Teva

$31.81

0.68 (2.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 02

    May

  • 03

    May

  • 04

    May

  • 04

    May

  • 07

    May

  • 09

    May

  • 11

    May

  • 31

    May

  • 06

    Jun

  • 08

    Jun

  • 27

    Aug

  • 30

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.